- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01379911
Developing Methods for Completing Future Satiety Studies
Developing and Validating a Method for Satiety Studies
Satiety is defined as the inhibition of eating, as a consequence of fullness after consuming food. Being able to effectively measure satiety is an important concept that has implications in the treatment and prevention of overweight and obesity. Increasing post-meal satiety is recognized a useful strategy for weight management. Recently, the category of foods marketed as having satiating effects has seen significant growth and this trend is expected to continue. The purpose of this project is to develop and validate methods for assessing the degree of satiety induced by foods and natural health products using commercially available food products.
This trial will examine the effects of a commercially available yogurt (containing added protein and fibre) on self-reported satiety and hunger, as well as food intake in both controlled and uncontrolled settings.
Studienübersicht
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Ontario
-
Guelph, Ontario, Kanada, N1G2W1
- Human Nutraceutical Research Unit, University of Guelph
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Healthy women with regular hormonal contraceptive use, aged between 20 and 35 years
- BMI of 20.0-24.9 kg/m2
- Regular yogurt consumers (i.e. > 3 servings per week)
Exclusion Criteria:
- Taking any regular medications or herbal supplements other than a multivitamin or folic acid supplement.
- History of cardiovascular disease (including hypertension), diabetes, hypoglycemia, gum disease or any other medical condition
- Vegans or vegetarians who exclude dairy products
- Milk allergies or any other food allergies
- Anyone with known anaphylactic allergic reactions, food or otherwise
- Dislike or unwillingness to consume study foods
- Gastrointestinal disease or disorders, including Celiac disease, lactose intolerance, irritable bowel syndrome, etc.
- BMI <20.0 or > 25.0 kg/m2
- Current participation in diet/weight-loss programs and/or changes of > 5 kg body weight within the past 6 months
- Unusual dietary patterns (i.e. routinely skipping breakfast or other meals)
- Unusual sleep patterns (i.e. shift workers)
- High habitual intake of caffeinated beverages or alcohol
- Restrained or disinhibited eaters, defined by the Three Factor Eating Questionnaire
- Smokers
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Yogurt with added inulin
Yogurt with 6g of added inulin
|
|
|
Placebo-Komparator: Regular yogurt
Regular yogurt without added inulin
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Self-reported ratings of satiety
Zeitfenster: Outcome measures will be assessed at fasting (0 min) and postprandially (every 30 min) for 3 hours.
|
The study consists of two trial days (pre- and post home consumption) per study period, one for each of 2 yogurts.
Each study visit involves a 4-hour stay at the HNRU.
The pre-study visit will be followed by a 6-day yogurt self-administration period where participants will consume the assigned yogurt at breakfast.
Thus, the acute satiety effects of the yogurts will be replicated in a controlled (laboratory) setting and evaluated over a 6-day period in an uncontrolled (home/lifestyle) environment.
|
Outcome measures will be assessed at fasting (0 min) and postprandially (every 30 min) for 3 hours.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Food intake
Zeitfenster: One week
|
Study will include food and caloric intake over entire study day and for 6 days subsequent to initial study visit.
|
One week
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Amanda J Wright, Ph.D., University of Guelph
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 11AP036
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Mangel an Sättigung
-
National Taiwan University HospitalNoch keine Rekrutierung
-
Imperial College LondonAbgeschlossenProof of Concept -StudieVereinigtes Königreich
-
University of RegensburgAbgeschlossenTrain-of-Four-MonitoringDeutschland
-
Research Unit Of General Practice, CopenhagenUniversity of Copenhagen; Region Capital Denmark; The Copenhagen General Practice... und andere MitarbeiterAbgeschlossen
-
Aalborg UniversityThe General Practice Foundation in Denmark (grant number A3495); The Novo Nordisk... und andere MitarbeiterAbgeschlossenPoint-of-Care-UltraschallDänemark
-
Kecioren Education and Training HospitalAbgeschlossenPoint-of-Care-SystemeTruthahn
-
Indiana UniversityRekrutierungPoint-of-Care-Ultraschall (POCUS)Vereinigte Staaten
-
Incyte CorporationVerfügbarSTAT1 Gain-of-Function-Erkrankung
-
Aalborg UniversityAbgeschlossenPoint-of-Care-Ultraschall (POCUS)Dänemark
-
Aalborg UniversityAbgeschlossen